13th-15th October, 2008, Amsterdam
Patient recruitment and retention in clinical trials is the leading bottleneck in the new drug development pipeline. As the recruiting culture becomes more sophisticated and the forces affecting patient enrolment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrolment in clinical trials.

Achieving success in this environment requires trial sponsors to play a larger role in the recruitment process and to develop more collaborative working relationships with all stakeholders, including investigators and patients.
Discuss   Add this link to...  Bury

Comments Who Voted Related Links